Kelty Earns K99/R00 NIH Grant for Alzheimer’s Research
Since 2021, Taylor Kelty, PhD, a research assistant professor at NextGen Precision Health, has looked to advance translational approaches for neurodegenerative diseases, with a focus on targeting metabolic dysfunction in Alzheimer’s disease (AD).